How about Wuxi Baonuo Sandia?

Baono-Sandia, one of Anhong's capital investment enterprises, is a leading contract research, process development and production company (CRDMO) in the industry, specializing in providing comprehensive services to biopharmaceutical customers and supporting drug discovery, development and production (including raw materials and finished drugs). As a leading CRDMO company in the industry, Baonuo-Sandia has 10 offices around the world, with more than 2,400 employees, mainly engaged in China and the United States.

Baonuo-Sandia has core expertise in the discovery, development and amplification of large and small molecules, supports IND declaration, and has a unique patented technology platform (such as a platform to enhance the bioavailability of insoluble compounds). The company has a center in R&D and production bases in China and the United States. Baonuo-Sandia adopts a "one-stop" operation mode, which effectively helps biopharmaceutical customers to speed up the discovery process and reduce the development risk, thus creating drugs with higher value.